Douglas M. Savage

Inhibition of Epidermal Growth Factor Receptor-Associated Tyrosine Phosphorylation in Human Carcinomas with CP-358,774: Dynamics of Receptor Inhibition In Situ and Antitumor Effects in Athymic Mice

Vincent A. Pollack, Douglas M. Savage, Deborah A. Baker et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 433 citations

Medicine, Oncology, Pharmacology +17

Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451

W. Gregory Roberts, Pamela Whalen, Erik Söderström et al. · Cancer Research · 2005 · 135 citations · Full text

Medicine, Oncology, Pharmacology +17

Generation of nonspecific murine cytotoxic T cells in vitro by purified human interleukin 2

Vincent J. Merluzzi, Douglas M. Savage, Roland Mertelsmann et al. · Cellular Immunology · 1984 · 60 citations

Life Sciences, Immunology, Cellular Immunology +12

Expansion of cyclophosphamide-resistant cytotoxic precursors in vitro and in vivo by purified human interleukin 2.

V J Merluzzi, Karl Welte, Douglas M. Savage et al. · The Journal of Immunology · 1983 · 59 citations

Life Sciences, Immunology, Pharmacology +15

Production and response to interleukin 2 in vitro and in vivo after bone marrow transplantation in mice.

V J Merluzzi, Karl Welte, K Last-Barney et al. · The Journal of Immunology · 1985 · 16 citations · Full text

Life Sciences, Immunology, Clinical Immunology +8